Cargando…

B lymphocyte mediated antigen presentation of plasmid DNA

Detalles Bibliográficos
Autores principales:	Colluru, Viswa Teja, McNeel, Douglas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990293/ http://dx.doi.org/10.1186/2051-1426-1-S1-P204

Ejemplares similares

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines
por: Colluru, Viswa Teja, et al.
Publicado: (2016)

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013)

SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013)

Role of B cells as antigen presenting cells
por: Rastogi, Ichwaku, et al.
Publicado: (2022)

Epigenetic regulation of CD1d-mediated antigen presentation in B cell lymphoma
por: Tiper, Irina, et al.
Publicado: (2014)

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
por: Johnson, Laura E., et al.
Publicado: (2017)

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010)

FcγR-mediated uptake and processing of antigen–immunoglobulin complexes by professional antigen-presenting cells
por: de Jong, JMH, et al.
Publicado: (2005)

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination
por: Becker, Jordan T, et al.
Publicado: (2013)

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
por: Forget, Marie-Andrée, et al.
Publicado: (2013)

Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2013)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells
por: Morishima, Chihiro, et al.
Publicado: (2014)

Intracellular trafficking pathways for plasmid DNA complexed with highly efficient endosome escape polymers
por: Gillard, Marianne, et al.
Publicado: (2015)

Using mass spectrometry to monitor drug induced changes in antigen presentation by the human leukocyte antigen
por: Illing, Patricia, et al.
Publicado: (2014)

PTEN in antigen presenting cells is a master regulator for Th17-mediated autoimmune pathology
por: Blüml, Stephan, et al.
Publicado: (2012)

P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
por: Tenzer, S, et al.
Publicado: (2009)

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation
por: Hallengärd, D, et al.
Publicado: (2009)

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients
por: Zirakzadeh, A Ali, et al.
Publicado: (2015)

Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOM
por: Singh, Harpreet, et al.
Publicado: (2014)

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression
por: Jeon, Donghwan, et al.
Publicado: (2022)

Activation of antigen-presenting cells by endogenous retroviral RNA
por: Moyes, D, et al.
Publicado: (2005)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
por: Morishima, Chihiro, et al.
Publicado: (2015)

Exploiting the activity of VP22 to enhance the delivery of antigens encoded by DNA vaccine plasmids
por: Roopchand, Vidia, et al.
Publicado: (2006)

The effect of chemotherapeutic drugs on human B lymphocytes
por: Zirakzadeh, Ali, et al.
Publicado: (2013)

Tolerance to lipopolysaccharide regulates apoptosis in B lymphocytes
por: de Sant Anna Melo, Edielle, et al.
Publicado: (2007)

Single-step nanoparticle antigen presentation system for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

Identification of potential immunotherapeutic targets in antigen presentation and costimulation networks
por: Spaapen, Robbert, et al.
Publicado: (2014)

Do circulating HIV vaccine plasmids contribute to immunogenicity in humans?
por: Wahren, B, et al.
Publicado: (2006)

TCR diversity – a universal cancer immunotherapy biomarker?
por: McNeel, Douglas G.
Publicado: (2016)

P11-13. Antigen presentation and immune priming of CCR5-ECL1 receptor in Peyer's patches B cells
por: Lopalco, L, et al.
Publicado: (2009)

Human circulating basophils lack the features of professional antigen presenting cells
por: Sharma, Meenu, et al.
Publicado: (2012)

Oncolytic poliovirus directs tumor antigen presentation and T cell activation in vitro
por: Brown, Michael C, et al.
Publicado: (2015)

Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
por: Bruno, Tullia, et al.
Publicado: (2015)

P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro
por: Quakkelaar, E, et al.
Publicado: (2009)

Does sustained downregulation of the TCRzeta chain define the transition from antigen mode to inflammation mode in effector T lymphocytes?
por: Cope, A, et al.
Publicado: (2003)

Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients
por: Cohen, Cyrille, et al.
Publicado: (2015)

Novel AIDS vaccine approach using epithelial stem cells as mucosal antigen-presenting cells
por: Bonello, G, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f6ohmo594eu1omfl8jdm568vag